Advertisement

Reactions Weekly

, Volume 1719, Issue 1, pp 37–37 | Cite as

Antineoplastics

Ibrutinib resistance from transformation of chronic lymphocytic leukaemia to diffuse large B‐cell lymphoma (Richter syndrome), febrile neutropenia and tumour lysis syndrome: 2 case reports
Case report
  • 31 Downloads

Reference

  1. Innocenti I, et al. Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia. Hematological Oncology 36: 600-603, No. 3, Aug 2018. Available from: URL: http://doi.org/10.1002/hon.2502 - ItalyCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations